Researchers from Tel Aviv University have developed scNET that tracks gene expression at the single-cell level in response to various therapies. It has exciting implications for research into cancer treatments and their effect on the tumor, pro-cancer supporting cells, and anti-cancer immune cells.
How cells respond to treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.